FDA 483 - KL Distributing - October 27, 2022

KL Distributing, a medical device specification developer in Hudson, FL, received an FDA Form 483 citing multiple quality system deficiencies. The inspection revealed inadequate procedures for purchasing controls, personnel training, and document control. Additionally, the firm's Medical Device Reporting procedures were incomplete, and top management failed to establish a quality policy or appoint a management representative.